Videos

Review of FDA DSCSA Guidance Documents

Review of FDA DSCSA Guidance Documents

Brian Daleiden of TraceLink reviews the latest requirements from the FDA and DSCSA

11.22.19
Related Searches:
Suggested For You
CMIC CMO USA CMIC CMO USA
Mogene Mogene
Biopharma Over 20 Years Biopharma Over 20 Years
Keynote: FDA’s Continuous Manufacturing Journey: Past, Present and Future Keynote: FDA’s Continuous Manufacturing Journey: Past, Present and Future
Inactive Ingredients: Where Guidance Needs to Meet Data Inactive Ingredients: Where Guidance Needs to Meet Data
Quality Metrics Feedback Quality Metrics Feedback
Continuous Manufacturing and its Regulatory Challenge Continuous Manufacturing and its Regulatory Challenge
Saudi Arabia 2019: Building a Comprehensive Compliance Strategy Saudi Arabia 2019: Building a Comprehensive Compliance Strategy
FDA Extends CRADA with CluePoints FDA Extends CRADA with CluePoints
FDA Approves New Treatment for Drug-Resistant TB FDA Approves New Treatment for Drug-Resistant TB
NIIMBL, FDA to Advance Innovation in Bio Manufacturing NIIMBL, FDA to Advance Innovation in Bio Manufacturing
FDA Accepts RedHill Biopharma’s NDA for Talicia FDA Accepts RedHill Biopharma’s NDA for Talicia
The FDA Gets Stricter with E&L Oversight, Can the Industry Keep Up? The FDA Gets Stricter with E&L Oversight, Can the Industry Keep Up?
Akorn Receives Warning Letter from FDA Akorn Receives Warning Letter from FDA
Sierra’s Momelotinib Granted FDA Fast Track Designation Sierra’s Momelotinib Granted FDA Fast Track Designation

Related Buyers Guide Companies

    Loading, Please Wait..